PATENT CLAIM ANALYSIS

Application Number: 15743424
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["546", "276700"]

Abstract:
The invention provides compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, wherein D 1 , D 2 , D 3 , X, Y, A 1 , A 2 , R 1 , R 5  and the subscript a are as described herein. The compounds are CETP inhibitors and are useful for raising FIDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis:

Claim (Index 6):
The compound of  claim 5 , or a pharmaceutically acceptable salt thereof, wherein\n R 1  is CF 3 ; D 1 , D 2 , and D 3  are CH 2 ; A 1  is phenyl or pyridyl, wherein A 1  is optionally substituted with 1-3 groups which are each independently F, \u2014OCH 3 , or isopropyl, and optionally one substituent group Z; Z is A 3  or \u2014CH 2 CH 2 CO 2 R 8 ; R 8  is H or \u2014CH 3 ; A 3  is phenyl, cyclohexyl, or pyridyl, wherein A 3  is optionally substituted with 1-2 groups \u2014CH 3  and is optionally substituted with 1 group \u2014CO 2 R 8 ; and A 2  is phenyl or pyridinyl, wherein A 2  is substituted with 1-2 groups which are selected from CF 3  and F.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 86.0
- Lexical Diversity: 1.63043
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14908180', '13660010', '15329284', '15104351', '15028306']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8423656253732175
- 35 USC 102 Novelty (BERT): 0.5669063200915722
- Combined Prediction Score: 0.814819694845053
- Mean Citation Score: 434.067694
- Max Citation Score: 454.36414
- Similarity Product: 419.4739081239176

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test